Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bronchopulmonary penetration of isavuconazole in lung transplant recipients
2019-004240-30Phase 4Active
- Sponsor
- Fundación de Investigación Biomédica Hospital Puerta de Hierro
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of isavuconazole in invasive mycoses, sponsored by Fundación de Investigación Biomédica Hospital Puerta de Hierro. Primary endpoint: Isavuconazole penetration in lung. Started Dec 2019; status: active.
02
Drugs
isavuconazole
03
Conditions
invasive mycoses
Beyond the preview
Go deeper on 2019-004240-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004240-30.